← Back to All Filings

Elanco EVP Buys $96K in Company Stock (ELAN)

Low SignificanceDecember 15, 2025 at 5:05:56 PM EST

Elanco Animal Health Inc

$ELAN4CIK: 0001739104

Subscribe to track ELAN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Elanco EVP Buys $96K in Company Stock (ELAN)

Company: Elanco Animal Health Inc (ELAN) Form: 4 | Filed: 2025/12/15 Significance: Low

Insider: Modi Rajeev A. Title: Executive Vice President U.S. Pet Health and Global Digital Transformation | Relationship: Officer

Transaction: • Type: Purchase • Shares: 4,500 • Price: $21.33 • Value: $95,985 • Owned After: 123,082

Key Insight: An executive purchased shares, which is a positive sign, but the transaction value is very small compared to the company's $10.48B market cap, making it a low-significance event.

Market Context: This is a routine-sized open market purchase for an executive at a large-cap company. It increases the insider's holdings by approximately 3.8%.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Elanco Animal Health Inc (ELAN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An executive made a small open-market purchase of common stock, representing a minor increase in their personal holdings and an immaterial transaction relative to the company's market capitalization.
  • Market Impact: The transaction is too small to have a meaningful impact on the stock's price or trading volume.

Company Information

FieldValue
CompanyElanco Animal Health Inc
Ticker SymbolELAN
CIK0001739104
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameModi Rajeev A.
CIK0001916473
Title/PositionExecutive Vice President U.S. Pet Health and Global Digital Transformation
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-11
Transaction CodeP (Open market purchase)
Security TypeCommon Stock
Shares Involved4,500
Price Per Share$21.33
Total Value$95,985
Shares Owned After123,082
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$95,985
% of Market Cap0.0009%
Shares Transacted4,500
% of Shares OutstandingNot Available
Post-Transaction Ownership123,082 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Elanco Animal Health Inc. is a large-cap company with a market capitalization of $10.48 billion. The transaction value of approximately $96k is negligible in this context.
  • Ownership Concentration: The insider's post-transaction holding is 123,082 shares. Without data on total shares outstanding, a precise ownership percentage cannot be calculated, but it is expected to be a very small fraction of the company.
  • Transaction Significance: The purchase represents less than 0.001% of the company's market capitalization. This falls far below the thresholds for moderate or high significance, indicating a routine transaction with minimal market signaling value.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: While an insider purchase is technically a bullish signal, the transaction size is immaterial relative to the company's market cap. It is unlikely to influence investor sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction is too small to affect trading volume.
  • Sentiment Indicator: Neutral. The purchase is a minor vote of confidence but not substantial enough to be considered a strong bullish indicator.

Additional Context

Transaction Notes

  • Footnotes: The filing notes that the total shares owned includes shares acquired via the company's Employee Stock Purchase Plan, which are routine acquisitions.
  • Special Circumstances: This was a standard open market purchase (Code 'P') and not part of a pre-arranged 10b5-1 trading plan.
Topics:#InsiderTrading#SECFiling#Form4#Elanco#ELAN#InsiderBuy#StockMarket#Investing#AnimalHealth

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.